Additional information
| Active substance | Ostarine |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Mild risk |
| Lab Test | Detection in blood and urine through specific chromatographic techniques |
| Also known as | Enobosarm, GTx-024 |
| Blood pressure | No significant impact |
| Trade name | Enobosarm |
| FORM | 50 tabs x 10 mg/tab |
| Storage conditions | Store at room temperature, away from moisture and light |
| Chemical name | (2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide |
| Formula | C19H14F3N3O3 |
| Substance class | Selective Androgen Receptor Modulator (SARM) |
| Main action | Anabolic, muscle growth stimulation |
| Half-life | 24 hours |
| Dosage (medical) | Not medically approved, no standard dosage |
| Dosage (sports) | 10-30 mg per day |
| Effects | Increases muscle mass and strength, improves bone density |
| Side effects | Possible liver toxicity, changes in lipid profiles, suppression of natural testosterone production |
| Use in sports | Used for muscle growth and performance enhancement, banned in professional sports |
| Manufacturer | Driada Medical |
Reviews
There are no reviews yet.